Abstract
The advancement of minimally invasive surgery, a clearer definition of the role of radiation therapy, and the incorporation of immunotherapy have changed the management of esophagogastric cancers. Novel agents targeting new pathways continue to move forward.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have